APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Immunoglobulin For Intramuscular Injection (IMIG)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Analysis and Forecast 2026-2032

23 December 2025192 pages

Choose your research edition.

Industry ResearchHuman Immunoglobulin For Intramuscular Injection (IMIG) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Human Immunoglobulin For Intramuscular Injection (IMIG) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Immunoglobulin For Intramuscular Injection (IMIG) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Immunoglobulin For Intramuscular Injection (IMIG) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Human Immunoglobulin For Intramuscular Injection (IMIG) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Immunoglobulin For Intramuscular Injection (IMIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Immunoglobulin For Intramuscular Injection (IMIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Immunoglobulin For Intramuscular Injection (IMIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Immunoglobulin For Intramuscular Injection (IMIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Immunoglobulin For Intramuscular Injection (IMIG) include Takeda, Tiantan Biological, CSL Behring, Grifols, Pfizer, Hualan Biological, Henjiu, Octapharma and Kedrion Biopharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Immunoglobulin For Intramuscular Injection (IMIG), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Immunoglobulin For Intramuscular Injection (IMIG), also provides the sales of main regions and countries. Of the upcoming market potential for Human Immunoglobulin For Intramuscular Injection (IMIG), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Immunoglobulin For Intramuscular Injection (IMIG) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Immunoglobulin For Intramuscular Injection (IMIG) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Immunoglobulin For Intramuscular Injection (IMIG) sales, projected growth trends, production technology, application and end-user industry.

Human Immunoglobulin For Intramuscular Injection (IMIG) Segment by Company

Takeda

Tiantan Biological

CSL Behring

Grifols

Pfizer

Hualan Biological

Henjiu

Octapharma

Kedrion Biopharma

Human Immunoglobulin For Intramuscular Injection (IMIG) Segment by Type

Children

Adult

Human Immunoglobulin For Intramuscular Injection (IMIG) Segment by Application

Disease Prevention

Diagnosis

Treatment

Other

Human Immunoglobulin For Intramuscular Injection (IMIG) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Immunoglobulin For Intramuscular Injection (IMIG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Immunoglobulin For Intramuscular Injection (IMIG) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Immunoglobulin For Intramuscular Injection (IMIG).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Immunoglobulin For Intramuscular Injection (IMIG) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Immunoglobulin For Intramuscular Injection (IMIG) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Immunoglobulin For Intramuscular Injection (IMIG) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Children Major Manufacturers Table 3. Adult Major Manufacturers Table 4. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Disease Prevention Major Manufacturers Table 6. Diagnosis Major Manufacturers Table 7. Treatment Major Manufacturers Table 8. Other Major Manufacturers Table 9. Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Trends Table 10. Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Drivers Table 11. Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Opportunities and Challenges Table 12. Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Restraints Table 13. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Region (2021-2026) Table 17. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Region (2027-2032) Table 18. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region (2021-2026) & (k units) Table 20. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region (2027-2032) & (k units) Table 21. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Region (2021-2026) Table 22. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Region (2027-2032) Table 23. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Manufacturers (2021-2026) Table 27. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price (USD/unit) of Manufacturers (2021-2026) Table 28. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturers, Product Type & Application Table 31. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Human Immunoglobulin For Intramuscular Injection (IMIG) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Type (2021-2026) Table 38. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Type (2027-2032) Table 39. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (k units) Table 41. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2027-2032) & (k units) Table 42. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2021-2026) Table 43. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2027-2032) Table 44. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Type (2021-2026) & (USD/unit) Table 45. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Type (2027-2032) & (USD/unit) Table 46. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Application (2021-2026) Table 50. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Application (2027-2032) Table 51. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026) & (k units) Table 53. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2027-2032) & (k units) Table 54. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Application (2021-2026) Table 55. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Application (2027-2032) Table 56. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Application (2021-2026) & (USD/unit) Table 57. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Application (2027-2032) & (USD/unit) Table 58. Takeda Company Information Table 59. Takeda Business Overview Table 60. Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 62. Takeda Recent Development Table 63. Tiantan Biological Company Information Table 64. Tiantan Biological Business Overview Table 65. Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 67. Tiantan Biological Recent Development Table 68. CSL Behring Company Information Table 69. CSL Behring Business Overview Table 70. CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 72. CSL Behring Recent Development Table 73. Grifols Company Information Table 74. Grifols Business Overview Table 75. Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 77. Grifols Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 82. Pfizer Recent Development Table 83. Hualan Biological Company Information Table 84. Hualan Biological Business Overview Table 85. Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 87. Hualan Biological Recent Development Table 88. Henjiu Company Information Table 89. Henjiu Business Overview Table 90. Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 92. Henjiu Recent Development Table 93. Octapharma Company Information Table 94. Octapharma Business Overview Table 95. Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 97. Octapharma Recent Development Table 98. Kedrion Biopharma Company Information Table 99. Kedrion Biopharma Business Overview Table 100. Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 102. Kedrion Biopharma Recent Development Table 103. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (k units) Table 106. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2027-2032) & (k units) Table 107. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Type (2021-2026) & (USD/unit) Table 108. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Type (2027-2032) & (USD/unit) Table 109. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026) & (k units) Table 112. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2027-2032) & (k units) Table 113. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Application (2021-2026) & (USD/unit) Table 114. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Application (2027-2032) & (USD/unit) Table 115. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 117. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 118. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 119. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026) & (k units) Table 120. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2027-2032) & (k units) Table 121. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Country (2021-2026) & (USD/unit) Table 122. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Country (2027-2032) & (USD/unit) Table 123. United States Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 124. Canada Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 125. Mexico Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 126. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (k units) Table 129. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2027-2032) & (k units) Table 130. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Type (2021-2026) & (USD/unit) Table 131. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Type (2027-2032) & (USD/unit) Table 132. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026) & (k units) Table 135. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2027-2032) & (k units) Table 136. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Application (2021-2026) & (USD/unit) Table 137. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Application (2027-2032) & (USD/unit) Table 138. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 142. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026) & (k units) Table 143. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2027-2032) & (k units) Table 144. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Country (2021-2026) & (USD/unit) Table 145. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Country (2027-2032) & (USD/unit) Table 146. Germany Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 147. France Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 148. U.K. Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 149. Italy Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 150. Russia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 151. Spain Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 153. Switzerland Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 154. Sweden Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 155. Poland Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 156. China Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021-2026) & (US$ Million) Table 157. China Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2027-2032) & (US$ Million) Table 158. China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (k units) Table 159. China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2027-2032) & (k units) Table 160. China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Type (2021-2026) & (USD/unit) Table 161. China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Type (2027-2032) & (USD/unit) Table 162. China Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021-2026) & (US$ Million) Table 163. China Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2027-2032) & (US$ Million) Table 164. China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026) & (k units) Table 165. China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2027-2032) & (k units) Table 166. China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Application (2021-2026) & (USD/unit) Table 167. China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Application (2027-2032) & (USD/unit) Table 168. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (k units) Table 171. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2027-2032) & (k units) Table 172. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Type (2021-2026) & (USD/unit) Table 173. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Type (2027-2032) & (USD/unit) Table 174. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026) & (k units) Table 177. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2027-2032) & (k units) Table 178. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Application (2021-2026) & (USD/unit) Table 179. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Application (2027-2032) & (USD/unit) Table 180. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 184. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026) & (k units) Table 185. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2027-2032) & (k units) Table 186. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Country (2021-2026) & (USD/unit) Table 187. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Country (2027-2032) & (USD/unit) Table 188. Japan Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 189. South Korea Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 190. India Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 191. Australia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 192. Taiwan Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 194. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2026) & (k units) Table 197. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2027-2032) & (k units) Table 198. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Type (2021-2026) & (USD/unit) Table 199. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Type (2027-2032) & (USD/unit) Table 200. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2026) & (k units) Table 203. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2027-2032) & (k units) Table 204. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Application (2021-2026) & (USD/unit) Table 205. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Application (2027-2032) & (USD/unit) Table 206. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 210. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026) & (k units) Table 211. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2027-2032) & (k units) Table 212. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Country (2021-2026) & (USD/unit) Table 213. SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Country (2027-2032) & (USD/unit) Table 214. Brazil Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 215. Argentina Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 216. Chile Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 217. Colombia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 218. Peru Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 220. Israel Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 221. UAE Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 222. Turkey Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 223. Iran Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 224. Egypt Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Human Immunoglobulin For Intramuscular Injection (IMIG) Distributors List Table 228. Human Immunoglobulin For Intramuscular Injection (IMIG) Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Human Immunoglobulin For Intramuscular Injection (IMIG) Image Figure 2. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Children Image Figure 5. Adult Image Figure 6. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Disease Prevention Image Figure 9. Diagnosis Image Figure 10. Treatment Image Figure 11. Other Image Figure 12. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (2021-2032) & (US$ Million) Figure 14. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Region (2021-2032) Figure 17. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (2021-2032) & (k units) Figure 18. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Human Immunoglobulin For Intramuscular Injection (IMIG) Sales YoY (2021-2032) & (k units) Figure 21. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales YoY (2021-2032) & (k units) Figure 22. China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Human Immunoglobulin For Intramuscular Injection (IMIG) Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales YoY (2021-2032) & (k units) Figure 25. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Type (2021-2032) Figure 31. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2021-2032) Figure 34. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Application (2021-2032) Figure 37. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Application (2021-2032) Figure 40. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Share by Type (2021-2032) Figure 41. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Share by Type (2021-2032) Figure 42. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Share by Application (2021-2032) Figure 43. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Share by Application (2021-2032) Figure 44. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Share by Country (2021-2032) Figure 45. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Share by Country (2021-2032) Figure 46. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Share by Type (2021-2032) Figure 47. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Share by Type (2021-2032) Figure 48. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Share by Application (2021-2032) Figure 49. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Share by Application (2021-2032) Figure 50. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Share by Country (2021-2032) Figure 51. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Share by Country (2021-2032) Figure 52. China Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Share by Type (2021-2032) Figure 53. China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Share by Type (2021-2032) Figure 54. China Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Share by Application (2021-2032) Figure 55. China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Share by Application (2021-2032) Figure 56. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Share by Type (2021-2032) Figure 57. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Share by Type (2021-2032) Figure 58. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Share by Application (2021-2032) Figure 59. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Share by Application (2021-2032) Figure 60. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Share by Country (2021-2032) Figure 61. Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Share by Country (2021-2032) Figure 62. SAMEA Human Immunoglobulin

Scope & coverage.

Types
  • Children
  • Adult
Applications
  • Disease Prevention
  • Diagnosis
  • Treatment
  • Other
Companies covered
  • Takeda
  • Tiantan Biological
  • CSL Behring
  • Grifols
  • Pfizer
  • Hualan Biological
  • Henjiu
  • Octapharma
  • Kedrion Biopharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Market by Type
  3. 1.2.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Children
  5. 1.2.3 Adult
  6. 1.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Market by Application
  7. 1.3.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Disease Prevention
  9. 1.3.3 Diagnosis
  10. 1.3.4 Treatment
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Human Immunoglobulin For Intramuscular Injection (IMIG) Market Dynamics
  1. 2.1 Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Trends
  2. 2.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Drivers
  3. 2.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Opportunities and Challenges
  4. 2.4 Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Region
  3. 3.2.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region
  9. 3.4.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region (2021-2026)
  11. 3.4.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region (2027-2032)
  12. 3.4.4 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Manufacturers
  2. 4.1.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Manufacturers
  6. 4.2.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturers, Product Type & Application
  13. 4.7 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market CR5 and HHI
  16. 4.8.2 2025 Human Immunoglobulin For Intramuscular Injection (IMIG) Tier 1, Tier 2, and Tier 3
5 Human Immunoglobulin For Intramuscular Injection (IMIG) Market by Type
  1. 5.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type
  2. 5.1.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type
  6. 5.2.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Type
6 Human Immunoglobulin For Intramuscular Injection (IMIG) Market by Application
  1. 6.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application
  2. 6.1.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application
  6. 6.2.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Tiantan Biological
  8. 7.2.1 Tiantan Biological Company Information
  9. 7.2.2 Tiantan Biological Business Overview
  10. 7.2.3 Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  12. 7.2.5 Tiantan Biological Recent Developments
  13. 7.3 CSL Behring
  14. 7.3.1 CSL Behring Company Information
  15. 7.3.2 CSL Behring Business Overview
  16. 7.3.3 CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  18. 7.3.5 CSL Behring Recent Developments
  19. 7.4 Grifols
  20. 7.4.1 Grifols Company Information
  21. 7.4.2 Grifols Business Overview
  22. 7.4.3 Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  24. 7.4.5 Grifols Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 Hualan Biological
  32. 7.6.1 Hualan Biological Company Information
  33. 7.6.2 Hualan Biological Business Overview
  34. 7.6.3 Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  36. 7.6.5 Hualan Biological Recent Developments
  37. 7.7 Henjiu
  38. 7.7.1 Henjiu Company Information
  39. 7.7.2 Henjiu Business Overview
  40. 7.7.3 Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  42. 7.7.5 Henjiu Recent Developments
  43. 7.8 Octapharma
  44. 7.8.1 Octapharma Company Information
  45. 7.8.2 Octapharma Business Overview
  46. 7.8.3 Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  48. 7.8.5 Octapharma Recent Developments
  49. 7.9 Kedrion Biopharma
  50. 7.9.1 Kedrion Biopharma Company Information
  51. 7.9.2 Kedrion Biopharma Business Overview
  52. 7.9.3 Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  54. 7.9.5 Kedrion Biopharma Recent Developments
8 North America
  1. 8.1 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Type
  2. 8.1.1 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2032)
  4. 8.1.3 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Type (2021-2032)
  5. 8.2 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Application
  6. 8.2.1 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2032)
  8. 8.2.3 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Application (2021-2032)
  9. 8.3 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Country
  10. 8.3.1 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Type
  2. 9.1.1 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Type (2021-2032)
  5. 9.2 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Application
  6. 9.2.1 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Application (2021-2032)
  9. 9.3 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Country
  10. 9.3.1 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Type
  2. 10.1.1 China Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021-2032)
  3. 10.1.2 China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2032)
  4. 10.1.3 China Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Type (2021-2032)
  5. 10.2 China Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Application
  6. 10.2.1 China Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021-2032)
  7. 10.2.2 China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2032)
  8. 10.2.3 China Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Type
  2. 11.1.1 Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Type (2021-2032)
  5. 11.2 Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Application
  6. 11.2.1 Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Application (2021-2032)
  9. 11.3 Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Country
  10. 11.3.1 Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Type
  2. 12.1.1 SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Type (2021-2032)
  5. 12.2 SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Application
  6. 12.2.1 SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Application (2021-2032)
  9. 12.3 SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Country
  10. 12.3.1 SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Immunoglobulin For Intramuscular Injection (IMIG) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Immunoglobulin For Intramuscular Injection (IMIG) Value Chain Analysis
  2. 13.1.1 Human Immunoglobulin For Intramuscular Injection (IMIG) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Immunoglobulin For Intramuscular Injection (IMIG) Production Mode & Process
  6. 13.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Distributors
  9. 13.2.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst